Table 2 Initial presentation and laboratory data at diagnosis
Overall | Surgical intervention | Catheter intervention | Thrombolytic therapy | Anticoagulation only | |
|---|---|---|---|---|---|
Number | 76 | 16 | 16 | 16 | 28 |
Initial presentation | |||||
Out-of-hospital onset | 60 (79.0%) | 11 (68.8%) | 12 (75.0%) | 15 (93.8%) | 22 (78.6%) |
Arrest/collapse at diagnosis | 67 (88.2%) | 12 (75.0%) | 13 (81.3%) | 15 (93.8%) | 27 (96.4%) |
Arrest at diagnosis | 52 (68.4%) | 10 (62.5%) | 11 (68.8%) | 7 (43.8%) | 24 (85.7%) |
Collapse at diagnosis | 15 (19.7%) | 2 (12.5%) | 2 (12.5%) | 8 (50.0%) | 3 (10.7%) |
Concomitant DVT | 41 (54.0%) | 12 (75.0%) | 10 (62.5%) | 9 (56.3%) | 10 (35.7%) |
ECMO use at hospital arrival | 61 (80.3%) | 13 (81.3%) | 12 (75.0%) | 12 (75.0%) | 24 (85.7%) |
Laboratory data at diagnosis | |||||
WBC (/μL) | 11,250 [9425–15,000] | 10,150 [8937–19,450] | 12,050 [8550–15,750] | 11,350 [9900–14,100] | 11,250 [9425–15,067] |
Hemoglobin (g/dL) | 12.0 [10.1–14.3] | 11.0 [8.9–13.3] | 13.3 [10.0–14.6] | 14.2 [11.8–16.0] | 11.6 [9.7–13.7] |
Platelet (109/μL) | 16.7 [11.6–23.7] | 17.0 [10.5–24.3] | 19.2 [14.6–22.6] | 16.1 [12.4–22.3] | 15.8 [10.5–25.6] |
Total bilirubin (mg/dL) | 0.6 [0.4–0.8] | 0.8 [0.7–1.45] | 0.6 [0.4–0.8] | 0.6 [0.5–0.8] | 0.6 [0.3–0.8] |
AST (IU/L) | 111 [43–230] | 77 [41–144] | 142 [35–252] | 120 [29–222] | 122 [59–274] |
ALT (IU/L) | 80 [39–177] | 47 [20–113] | 85 [67–182] | 54 [24–162] | 114 [52–233] |
Serum creatinine (mg/dL) | 1.03 [0.83–1.33] | 0.94 [0.78–1.10] | 0.96 [0.79–1.16] | 1.13 [0.93–1.33] | 1.09 [0.86–1.45] |
eGFR (mL/min/1.73m2) | 49.9 [40.1–60.3] | 50.1 [43.6–60.8] | 51.0 [38.6–70.5] | 52.9 [40.7–56.4] | 43.5 [38.7–58.6] |
D-dimer (μg/mL) | 28.1 [13–49] | 33.2 [12.8–57.3] | 26.3 [14.3–33.5] | 21.5 [10.6–66.0] | 34.5 [9.4–51.9] |
BNP (pg/mL) | 225.6 [70.1–592.7] | 605.2 [58.6–892.8] | 330.1 [32.5–918.5] | 307.7 [29.5–713.3] | 183.9 [83.0–460.5] |